세계의 금연 제품 시장 보고서(2025년)
Smoking Cessation Products Global Market Report 2025
상품코드 : 1769759
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 금연 제품 시장 규모는 향후 수년간 강력한 성장이 전망됩니다.

흡연 관련 질병의 유병률 증가는 향후 몇 년 동안 금연 제품 시장의 성장을 가속할 것으로 예측됩니다. 화학물질에 대한 노출을 길게 하여 장기적인 손상과 만성질환의 위험 상승으로 이어질 것입니다. 예를 들어, 2025년 1월에 미국 암 협회가 발표한 바에 따르면, 미국에서는 2025년에 약 22만 6650명의 폐암 환자가 새롭게 발생할 것으로 예측되고 있으며, 그 내역은 남성이 11만 0680명, 여성이 11만 5970명입니다. 폐암 관련 사망은 약 124,730명에 이를 것으로 예상되며, 그 내역은 남성 64,190명, 여성 60,540명입니다.

금연 제품 시장에서 사업을 전개하는 기업은 회복의 성과를 향상시키고 재발을 예방하기 위해 인지도를 높이고 지역사회의 지원을 촉진하는 탈중독 캠페인을 시작하는 것을 중시하고 있습니다. 2023년 4월, Rusan Pharma는 24시간 니코틴 경피 패치를 제공하는 자사 브랜드 2baconil을 통해 금연 캠페인을 도입했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Smoking cessation products are therapeutic solutions developed to support individuals in reducing or completely stopping their tobacco use by addressing both the physical and psychological dependencies associated with nicotine addiction. These aids operate by either progressively decreasing nicotine levels in the body or offering alternatives that help manage cravings and withdrawal symptoms.

The primary categories of smoking cessation products include nicotine replacement therapy (NRT), prescription medications, over-the-counter remedies, and electronic cigarettes. NRT is a clinically approved method that delivers controlled amounts of nicotine to ease withdrawal symptoms and support smoking cessation efforts. It comes in various forms such as patches, gums, lozenges, nasal sprays, and inhalers, and is available through pharmacies, online platforms, supermarkets, and medical professionals. These products cater to a wide range of users, including adults, adolescents, and expectant mothers.

The smoking cessation products market research report is one of a series of new reports from The Business Research Company that provides smoking cessation products market statistics, including smoking cessation products industry global market size, regional shares, competitors with a smoking cessation products market share, detailed smoking cessation products market segments, market trends and opportunities, and any further data you may need to thrive in the smoking cessation products industry. This smoking cessation products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smoking cessation products market size has grown strongly in recent years. It will grow from $22.25 billion in 2024 to $24.13 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. This historical growth can be credited to heightened awareness regarding the health dangers of smoking, an increase in smoking-related respiratory conditions, extensive government and public health initiatives encouraging smoking cessation, wider adoption of nicotine replacement solutions, and increased spending on healthcare due to smoking-related diseases.

The smoking cessation products market size is expected to see strong growth in the next few years. It will grow to $32.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth will be driven by a rising number of individuals trying to quit smoking, the aging population with historically high smoking rates, favorable regulatory frameworks supporting cessation programs, a surge in tobacco-related cancer cases, and the implementation of more rigorous tobacco control measures and taxation policies. Key trends in the forecast period include diversification of product offerings, continued use of nicotine replacement therapies, improved ease of access to cessation solutions, integration of behavioral therapies with pharmacological aids, and advancements in technology for nicotine delivery methods.

The increasing prevalence of smoking-related diseases is expected to drive the growth of the smoking cessation products market in the coming years. These diseases, which result directly or indirectly from tobacco use, impact various organs and systems within the body. The continued use of tobacco prolongs exposure to harmful chemicals, leading to long-term damage and an elevated risk of chronic conditions. As the incidence of these diseases rises, growing health awareness and medical diagnoses are encouraging more individuals to seek effective ways to quit smoking, thereby increasing demand for cessation products. For example, in January 2025, the American Cancer Society reported that the United States is projected to see approximately 226,650 new lung cancer cases in 2025, with 110,680 in males and 115,970 in females. Lung cancer-related deaths are expected to reach around 124,730, including 64,190 men and 60,540 women. This increasing burden of smoking-related illnesses underscores the growing market for smoking cessation products.

Companies operating in the smoking cessation products market are emphasizing the launch of de-addiction campaigns to raise awareness and foster community support that improves recovery outcomes and helps prevent relapse. These campaigns aim to support individuals struggling with substance dependence and promote healthier lifestyle choices. For instance, in April 2023, Rusan Pharma, an India-based pharmaceutical company, introduced a tobacco de-addiction campaign through its brand 2baconil, which offers a 24-hour nicotine transdermal patch. The campaign, titled #NoReasonIsGoodEnough, was built around the idea that individuals often justify their smoking habits with various reasons. It highlights how 2baconil's nicotine patches can help reduce both the physical and psychological reliance on nicotine. The brand's product offerings include both nicotine patches and gum to aid individuals in quitting smoking.

In April 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical firm, acquired the global Nicotine Replacement Therapy (NRT) business of Haleon Plc for $619 million. This acquisition brought into Dr. Reddy's portfolio Nicotinell, a leading global brand in nicotine replacement therapy with a presence in more than 30 countries across Europe, Asia, and Latin America. It also included other notable regional brands such as Nicabate, Thrive, and Habitrol. The product range includes lozenges, patches, gums, and other upcoming products, serving major international markets, excluding the United States. Haleon Plc is a UK-based company that manufactures smoking cessation products.

Major players in the smoking cessation products market are Pfizer Inc., Johnson & Johnson, Novartis AG, Imperial Brands PLC, GlaxoSmithKline (GSK), British American Tobacco PLC, Philip Morris International Inc., Haleon Group of Companies, Perrigo Company, Dr. Reddy's Laboratories, Cipla Ltd., Fertin Pharma, Lucy, Euro-Pharm International Canada Inc., Alkalon A/S, Enorama Pharma AB, Niconovum AB, Sparsha Pharma International Pvt Ltd, The Harvard Drug Group, and Revolymer.

North America was the largest region in the smoking cessation products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smoking cessation products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smoking cessation products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smoking cessation products market consists of sales of non-nicotine prescription medications, quit smoking supplements, and detox and recovery aids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smoking Cessation Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smoking cessation products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for smoking cessation products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smoking cessation products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Smoking Cessation Products Market Characteristics

3. Smoking Cessation Products Market Trends And Strategies

4. Smoking Cessation Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Smoking Cessation Products Growth Analysis And Strategic Analysis Framework

6. Smoking Cessation Products Market Segmentation

7. Smoking Cessation Products Market Regional And Country Analysis

8. Asia-Pacific Smoking Cessation Products Market

9. China Smoking Cessation Products Market

10. India Smoking Cessation Products Market

11. Japan Smoking Cessation Products Market

12. Australia Smoking Cessation Products Market

13. Indonesia Smoking Cessation Products Market

14. South Korea Smoking Cessation Products Market

15. Western Europe Smoking Cessation Products Market

16. UK Smoking Cessation Products Market

17. Germany Smoking Cessation Products Market

18. France Smoking Cessation Products Market

19. Italy Smoking Cessation Products Market

20. Spain Smoking Cessation Products Market

21. Eastern Europe Smoking Cessation Products Market

22. Russia Smoking Cessation Products Market

23. North America Smoking Cessation Products Market

24. USA Smoking Cessation Products Market

25. Canada Smoking Cessation Products Market

26. South America Smoking Cessation Products Market

27. Brazil Smoking Cessation Products Market

28. Middle East Smoking Cessation Products Market

29. Africa Smoking Cessation Products Market

30. Smoking Cessation Products Market Competitive Landscape And Company Profiles

31. Smoking Cessation Products Market Other Major And Innovative Companies

32. Global Smoking Cessation Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smoking Cessation Products Market

34. Recent Developments In The Smoking Cessation Products Market

35. Smoking Cessation Products Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기